share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

SEC ·  Sep 5 05:45
Summary by Futu AI
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a sale of company stock on September 3, 2024. The transaction involved the disposal of 114 shares of Moderna's common stock at a price of $76.989 per share, resulting in a total sale value of $8,776.75. Prior to this sale, Klinger exercised options to acquire 233 shares on August 30, 2024. Following these transactions, Klinger's direct holdings in Moderna stock amounted to 17,566 shares. The sale represents a routine transaction by a company insider, providing market participants with insights into executive behavior and confidence in the firm.
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a sale of company stock on September 3, 2024. The transaction involved the disposal of 114 shares of Moderna's common stock at a price of $76.989 per share, resulting in a total sale value of $8,776.75. Prior to this sale, Klinger exercised options to acquire 233 shares on August 30, 2024. Following these transactions, Klinger's direct holdings in Moderna stock amounted to 17,566 shares. The sale represents a routine transaction by a company insider, providing market participants with insights into executive behavior and confidence in the firm.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.